Ethical supplement manufacturer invests in new production facility

X The Business Desk

Register for free to receive latest news stories direct to your inbox


A Malvern Hills company has made what it is calling a “significant” investment in a new production facility to meet the growing demand in premium health supplements and formulas.

Cytoplan, currently located in Hanley Swan will open its new production facility in Malvern Link after another year of double-digit growth in its range of premium, food-based nutritional supplements.

The investment has been privately funded by the company after sales grew by over 20% in both 2020 and 2021 with a customer base of healthcare practitioners and consumers buying products across the UK, Europe and North America.

The company will retain its original building and split across the existing and new site.

The facility will meet the demand for its 100,000 annual customers and £10m turnover, of which profits go to supporting charitable owners The Aim Foundation – investing in health and nutrition projects across the UK and overseas.

The Multi-formula and Immune Health categories which include popular products such as Wholefood Multi have both grown 25%, while Cytoplan’s Vitamin D3 product has grown 37% in the last year alone. The new production facility; expertly designed to deliver on the company’s unique supplement formulas will allow Cytoplan to meet that demand and more for the next 3-5 years.

Amanda Williams; CEO of Cytoplan, said: “After 18 months of the Coronavirus pandemic the immune health category has grown by 25% with unforeseen growth in vitamins such as Vitamin D3 and this, alongside consumer surge in demand for supplements that are vegan and food-based, has helped us to continue to grow and improve the nation’s health by providing unique science-based supplements and formulas to both healthcare practitioners and direct to consumers via our website.

“It’s important for us to stick to the roots we have nurtured here in Malvern over the past 30 years and stay true to our ethical philosophy of working with nature and science to improve health.

“Although we have outgrown our current site, investing in an additional production facility will future proof the company and ensure we retain our local staff and keep Cytoplan growing here within the community for the foreseeable future.

“We are excited to continue to contribute to our charitable owners; The Aim Foundation which will see us positively impacting worthwhile health and nutrition projects both here in the UK and overseas.”